TC

Tayvant Chandrakant Tamboli

Active Director Director DIN 09703575
DIN 09703575 First appointment Aug 2022 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Tayvant Chandrakant Tamboli

Data last updated:

Tayvant Chandrakant Tamboli is a Director at Krisil Pharmaceuticals Private Limited (since 2022). The company operates in Trading.

DIN 09703575
Primary Designation Director
Industry Trading
First Appointment 12 Aug 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Aug 20222022Active

Board colleagues of Tayvant Chandrakant Tamboli

Directorship timeline

Open interactive timeline →
Krisil Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Tayvant Chandrakant Tamboli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tayvant Chandrakant Tamboli

Tayvant Chandrakant Tamboli currently holds 1 directorship: Krisil Pharmaceuticals Private Limited (Director, since 12 Aug 2022).

Tayvant Chandrakant Tamboli was first appointed on 12 Aug 2022 as Director at Krisil Pharmaceuticals Private Limited.

The current boards of Tayvant Chandrakant Tamboli's companies include Karan Tayvantbhai Tamboli (Krisil Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available